Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Differences Between Randomized Clinical Trial Patients and Real-World Initiators of the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide

Research output: Contribution to journalLetterResearchpeer-review

DOI

  1. The Liver-α-Cell Axis and Type 2 Diabetes

    Research output: Contribution to journalReviewResearchpeer-review

  2. Endogenous glucose-dependent insulinotropic polypeptide exerts diverging and tissue specific in obese patients with type 2 diabetes

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  3. The glucagon-like peptide-1 receptor agonist, liraglutide, does not suppress postprandial cholecystokinin in patients with type 1 diabetes

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  4. The role of glucagon-like peptide 1 for the postprandial effects of metformin in type 2 diabetes

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  5. The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion-A Review

    Research output: Contribution to journalReviewResearchpeer-review

  • Jakob Schöllhammer Knudsen
  • Reimar Wernich Thomsen
  • Anton Pottegård
  • Filip Krag Knop
  • Henrik Toft Sørensen
View graph of relations
Original languageEnglish
JournalDiabetes Care
Volume41
Issue number9
Pages (from-to)e133-e135
Number of pages2
ISSN1935-5548
DOIs
Publication statusPublished - Sep 2018

ID: 54769507